DIABETIC FOOT
CHAPTER 85 CAMPBELLS
HISTORY AND PHYSICAL EXAMINATION
The physician should inquire about :
 any episodes of ulceration
 prior amputations
 known neuropathic arthropathy
 impaired vision
 renal history
 presence of paresthesias or numbness
 any symptoms of claudication
 patients may deny any history of trauma or pain before the development of a foot ulcer
 A difference in skin temperature of the foot may indicate the presence of a
vascular disease
 Diminished or absent pulses require further testing with a Doppler examination
 The ankle-brachial index (ABI) is a useful noninvasive screening tool that is
predictive of wound healing. A normal ABI is 0.9 to 1.2 while values over 1.3
suggest noncompressible vessels due to calcification.
 An ABI of less than 0.5 suggests that an ulcer is unlikely to heal without vascular
intervention
 A difference in ABI of more than 0.15 between extremities is a significant finding
and should be further investigated.
 Absolute toe pressures should be higher than 70 mmHg, and a normal
toe/brachial index of more than 0.7 is normal.
 Toe pressures of more than 40 mmHg are associated with wound healing.
 A neurologic examination evaluates for the presence or absence of peripheral
neuropathy.
Semmes-Weinstein monofilament
 The inability to feel the 10 g of pressure from this monofilament is one of the
most predictive risk factors for development of foot morbidity.
 Typical screening involves 10 g monofilament testing of 10 sites on the foot
Diabetic Foot.pptx
 equivalent results can be obtained more quickly using a 4.5 g monofilament
beneath both first metatarsal heads.
 Decreased perception of the vibration of a 128 Hz tuning fork at the tip of the
great toe also is used in clinical practice.
ULCER CLASSIFICATION
 Ince et al. found that of 410 diabetic foot ulcers, 96% of those less than 1-2 cm in
dimension eventually healed without any form of amputation, while only 72% of
ulcers larger than 2-3 cm did so
Diabetic Foot.pptx
Diabetic Foot.pptx
Diabetic Foot.pptx
Diabetic Foot.pptx
Diabetic Foot.pptx
Diabetic Foot.pptx
Diabetic Foot.pptx
LABORATORY EVALUATION
 Patients with hemoglobin A1c levels higher than 7% or preoperative glucose levels
of more than 200 mg/dL before ankle or hindfoot arthrodesis have a higher rate of
complications, including nonunion, infection, and wound healing problems.
If infection is suspected clinically:
 complete blood count(CBC)
 erythrocyte sedimentation rate (ESR)
 C-reactive protein (CRP)
Diabetic Foot.pptx
TREATMENT
The primary goals of treatment of diabetic foot ulcers are :
 healing of the ulcer
 prevention of secondary infection
 recurrence
 avoidance of amputation
The most standard treatments are debridement and off-loading of the
affected area
Because of the complexities of treating diabetic feet, including :
impaired blood supply
osteoporotic bone
neuropathy
a multidisciplinary approach is most beneficial
Expertise often is needed from subspecialists in orthopaedics, vascular
Surgery , infectious disease , endocrinology, and wound nursing.
 Vascular consultation should be considered when rest pain , claudication , or
ischemic ulcers are present.
 Endocrinology may assist if blood glucose levels cannot be controlled by the
primary care practitioner or if the patient shows unusual response to standard
glycemic control measures.
 Infectious disease consultation may be helpful when a patient fails to respond to
empiric antibiotic therapy.
 Systemic factors, including glucose control , smoking, and diet, should be
controlled to optimize the wound-healing environment
Using the Wagner classification of foot ulcers:
 grade 0 ulcers should be treated with serial examinations, patient education,
accommodative footwear.
 Grade I ulcers can be treated with debridement in the clinic and off-loading
total contact cast, walking brace, or other custom footwear.
Grade II ulcers require
 surgical debridement
 culture-specific antibiotics
 off-loading with total anesthetic.
 Grade III ulcers require
surgical debridement or partial amputation with off-loading and culture specific
antibiotics.
 Grades IV and V ulcers require local or larger amputation based on the extent of
infection.
 In the ischemic classification of Brodsky et al :
 type B ischemia should be considered for noninvasive vascular testing and
reconstruction with bypass or angioplasty.
 Type C involvement may require reconstructive vascular surgery with partial
amputation
 while type D requires thorough vascular evaluation and likely major extremity
amputation.
 Negative pressure wound therapy(NPWT) devices are another option to assist in
ulcer healing.
 The exact mechanism of action of NPWT is unknown;however, studies have shown
that it may increase local blood flow, decrease edema, and increase the
concentration of growth factors in the local wound fluid
 Cultures of the ulcer generally are not recommended because the sensitivity in
isolating the causative organism is low
 Most ulcers are colonized with bacteria that has not invaded the deep tissue and
do not require antibiotics.
 When wound cultures are obtained , this should be done after thorough
debridement of the wound
 Harsh chemicals such as hydrogen peroxide and betadine should not be
applied because these can damage the viable tissue in the ulcer and further delay
healing.
 Routine nail care may be provided by the physician or nurse if the patient is
unable to do so.
 A straight nail clipper should be used to transversely cut the nail to avoid any skin
overgrowth at the medial and lateral borders, which may increase the chance of
developing an ingrown nail.
 Hyperbaric oxygen (HBO) has been used as a treatment for diabetic foot ulcers,
and randomized trials have shown 54% healing using HBO compared with 25%
for standard methods.
PATIENT EDUCATION
 Patient education for diabetic patients has been shown to be cost-effective,
improve patient quality of life, and reduce the risk of lower extremity amputation
by 50% to 85%.
 Patients should be reminded to wear shoes at all times.
 Feet should be inspected daily, and any signs of erythema, ulceration, or nail
problems should be brought to the attention of the care provider.
 Feet should be bathed daily with mild soap and a soft brush for the areas around
the nails.
 When drying the feet, attention should be paid to the web spaces because these
areas often trap moisture.
 If the web spaces remain overly moist, lamb’s wool may be placed in between the
toes to avoid maceration.
TOTAL CONTACT CASTING
 Reducing pressure on plantar ulcers is crucial to aid healing.
 Forefoot pressures can be reduced with prefabricated shoes more easily than
midfoot or hindfoot ulcers.
 Total contact casting is more effective than prefabricated shoes for the midfoot
and hindfoot (Fig. 85-11).
Diabetic Foot.pptx
Diabetic Foot.pptx
 A total contact cast redistributes forces from the plantar surface of the foot to
the leg , which reduces the force on the foot even with weight- Bearing activity.
 Total contact casting also is beneficial in that it reduces edema in the extremity,
which is why the cast must be changed regularly to prevent loosening that can
lead to further ulceration.
 Total contact casting for plantar ulcers showed significantly better healing (89.5%)
than removable prefabricated walking boots (65%) or shoes (58%).
Diabetic Foot.pptx
 This is similar to the 88% healing rate reported at 41 days with total contact
casting alone in a study comparing casting alone to casting with percutaneous
Achilles lengthening.
 Patients have been shown to decrease their activity over the course of a day in a
total contact cast, which reduces the stress on the foot.
 Total contact casting is not a benign treatment, however; it has been shown to
have a 6% to 17% occurrence of new ulcer formation and a 0.25% rate of
permanent sequelae
Contraindications of Total contact cast
 absolute:
 active or acute deep infection,gangrene(wagner grade 3-5)
 deep tissue infection
 osteomyelitis
 exposed tendone , joint and bone
 arterial insufficiency/gangrene
 Relative:
 severe obesity
 ulcer depth greater than ulcer width
 fragile skin
 fluctuating edema
 patient unwilling to have cast on limb
 patient unable to comply with follow up visit
 Doppler ABI less than ./4
SURGICAL MANAGEMENT
 Indications for surgical management are grossly contaminated wounds,
unbraceable deformity, gastrocnemius contracture, underlying bone prominence
that impedes wound healing, and failure of conservative management.
Prophylactic surgery may be considered in patients who are at risk for
wound breakdown because of joint instability or bony prominence.
 Flexor tenotomy as treatment for isolated toe ulcerations showed over 90%
healing rates in a mean of 40 days, with a 12% recurrence rate at 2-year follow up.
 Ulcerations at the medial interphalangeal joint of the hallux can be treated by
resection of the medial condyles of the proximal and distal phalanges.
 Plantar metatarsophalangeal joint ulcerations are common, difficult to heal, and
associated with a high risk of amputation.
 Achilles tendon lengthening and/or gastrocnemius recession should be
considered for patients with forefoot ulcers in whom conservative management
has failed and contractures have developed.
Diabetic Foot.pptx
 Exostectomy may be required in patients with bony deformity and ulceration.
 A sufficient period of off-loading with total contact casting should be completed
before surgery.
 For patients in whom other surgical management fails , who have non
reconstructable vascular disease, or in whom infection is uncontrollable,
amputation is the last surgical option.
 The National Diabetes Advisory Board estimates that approximately 5% to 15% of
diabetic patients will require a lower-extremity amputation in their lifetime.
 The level of amputation depends on the location of infection and likelihood of
healing of the surgical wound.
 One-year mortality after transtibial amputation is 20%, with a 5-year mortality
of 65%.
 Preservation of a portion of the foot gives the patient an end-bearing limb that
facilitates ambulation without a prosthesis and improves Functional outcome.
 In the forefoot, ray resection or transmetatarsal amputation may be sufficient
in a patient with palpable pulses; however, the same wound in a patient with
vascular pathology may require transtibial amputation
 In the midfoot,a talonavicular-calcaneocuboid disarticulation (Chopart) or syme
amputation may allow ambulation without prosthesis.
 A viable heel pad is required for a Syme amputation
Diabetic Foot.pptx
Lisfranc Amputation
Chopart amputation
Syme Amputation
Diabetic Foot.pptx
Diabetic Foot.pptx
Boyd Amputation
 The single most important factor predicting success of a partial foot amputation
is the hemoglobin A1C level at time of surgery, with some authors
recommending no elective or trauma surgery for a diabetic patient with an A1C
level of more than 8% unless necessary to save life or limb.
CHARCOT ARTHROPATHY
 Diabetes is the most common cause of Charcot arthropathy today, but other
etiologies include syphilis, heavy metal poisoning, alcoholic or congenital
neuropathy, leprosy, rheumatoid arthritis, and idiopathic causes
 The neurovascular, or French, theory was first proposed by Charcot and suggests
that neurologic damage precedes and is responsible for the destructive changes.
It proposes that damage to the nervous system causes autonomic dysfunction,
which increases local blood flow due to arteriovenous shunting and leads to bone
resorption
 The neurotraumatic, or German, theory supported by Virchow and Volkman
suggests that repetitive microtrauma causes the bony changes due to absent
protective mechanisms.
CLASSIFICATION
 Type 1 involving the tarsometatarsal and naviculocuneiform joints is most
common (60%). Midfoot involvement, specifically the tarsometatarsal joints
characterized by hindfoot valgus as a result of forefoot abduction with a
contracted gastrocsoleus complex
 Type 2 is the second most common type (25%) and primarily involves the
hindfoot, including the subtalar, talonavicular, and calcaneocuboid joints, and may
also progress to a rocker-bottom deformity
Diabetic Foot.pptx
 Type 3A (10%) involves the ankle and often results in ulcerations over the
prominent malleoli. Ankle involvement generally requires operative intervention
because of marked instability.
 Type 3B (5%) presents as a pathologic fracture of the calcaneal tuberosity from
avulsion
Diabetic Foot.pptx
Diabetic Foot.pptx
TREATMENT
 Stage 1 disease is treated with a total contact cast, which offloads the involved
region and provides stability and alignment through the healing phases.
 stage 2 , patients can be transitioned into a prefabricated boot or a custom-
molded ankle-foot-orthosis.
 When consolidation is complete and swelling resolves completely (stage 3)
intensive treatment, up to 50% may require surgical intervention
 Vitamin D supplementation should be considered for all patients because research
has shown frequent hypovitaminosis D in diabetic patients and clarified its role in
the pathogenesis and treatment of Charcot arthropathy.
 The primary goals of surgical intervention are to prevent ulceration, infection,
and amputation by decreasing sites of underlying pressure and improving
alignment and stability of the foot.
 Exostectomy is most beneficial in Brodsky type 1 deformities in which
tarsometatarsal destruction leads to rockerbottom deformity and increased
midfoot plantar pressures
 Patients with instability and resultant pain or ulceration may be best treated with
arthrodesis
 Type 1 deformities generally require midfoot arthrodesis, while type 2
deformities require triple arthrodesis
 In patients with uncontrollable infection or failed operative treatment, amputation
preserving as much length as possible may be the best option
 An estimated 2% to 3% of patients with Charcot arthropathy have amputations

More Related Content

PPTX
DIABETIC FOOT ULCER
PPTX
Diabetic foot
PPTX
DIABETIC FOOT PRESENTATION.pptx
PPT
The diabetic foot; state of the art
PPTX
Diabetic foot Dr Jitesh Jain
PPTX
Orthotic management of diabetes mellitus foot
PDF
diabetic foot ulceratif -180729053052.pdf
PPTX
Management of diabetic foot
DIABETIC FOOT ULCER
Diabetic foot
DIABETIC FOOT PRESENTATION.pptx
The diabetic foot; state of the art
Diabetic foot Dr Jitesh Jain
Orthotic management of diabetes mellitus foot
diabetic foot ulceratif -180729053052.pdf
Management of diabetic foot

Similar to Diabetic Foot.pptx (20)

PPTX
A diabetic patient with wound on foot
PPTX
Diabetic foot
PPT
Diabetic Foot
PPTX
Diabetic foot & ankle
PPTX
DIABETIC FOOT grading and management clinical
PPTX
Diabetic foot.pptx
PPTX
Diabetic Foot .pptx
PPTX
Diabetic foot
PDF
The-Diabetic-Foot-Diab-Ed-2014.pdf
PPTX
Diabetic foot presntation details about.pptx
PPTX
DIABETIC FOOT ULCER.pptx
PPTX
diabetic foot ulcer classification management .pptx
PPTX
Implementing Practical Guidelines in The Pevention and Management of Diabetes...
PPTX
Diabetic foot ulcer
PPTX
Diabetic foot
PPTX
DIABETIC FOOT.....powerpoint for surgery
PPTX
Diabeticfoot
PPTX
Diabetic foot and its complications -final.pptx
PPT
490464824-6-DIABETIC-FOOT-ppt.ppt..... -ppt.ppt
PPT
490464824-6-DIABETIC-FOOT-ppt.ppt.... pt.ppt.
A diabetic patient with wound on foot
Diabetic foot
Diabetic Foot
Diabetic foot & ankle
DIABETIC FOOT grading and management clinical
Diabetic foot.pptx
Diabetic Foot .pptx
Diabetic foot
The-Diabetic-Foot-Diab-Ed-2014.pdf
Diabetic foot presntation details about.pptx
DIABETIC FOOT ULCER.pptx
diabetic foot ulcer classification management .pptx
Implementing Practical Guidelines in The Pevention and Management of Diabetes...
Diabetic foot ulcer
Diabetic foot
DIABETIC FOOT.....powerpoint for surgery
Diabeticfoot
Diabetic foot and its complications -final.pptx
490464824-6-DIABETIC-FOOT-ppt.ppt..... -ppt.ppt
490464824-6-DIABETIC-FOOT-ppt.ppt.... pt.ppt.
Ad

Recently uploaded (20)

PPTX
Neoplasia III.pptxjhghgjhfj fjfhgfgdfdfsrbvhv
PPTX
Hypertensive disorders in pregnancy.pptx
PDF
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
PDF
Glaucoma Definition, Introduction, Etiology, Epidemiology, Clinical Presentat...
PPTX
Reading between the Rings: Imaging in Brain Infections
PPTX
Impression Materials in dental materials.pptx
PPTX
CARDIOVASCULAR AND RENAL DRUGS.pptx for health study
PDF
04 dr. Rahajeng - dr.rahajeng-KOGI XIX 2025-ed1.pdf
PPTX
ROJoson PEP Talk: What / Who is a General Surgeon in the Philippines?
PPT
Opthalmology presentation MRCP preparation.ppt
PDF
Forensic Psychology and Its Impact on the Legal System.pdf
PPTX
Post Op complications in general surgery
PPTX
SHOCK- lectures on types of shock ,and complications w
PPTX
thio and propofol mechanism and uses.pptx
PPTX
Vesico ureteric reflux.. Introduction and clinical management
PPTX
ANESTHETIC CONSIDERATION IN ALCOHOLIC ASSOCIATED LIVER DISEASE.pptx
PDF
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
PPT
Infections Member of Royal College of Physicians.ppt
PDF
OSCE SERIES - Set 7 ( Questions & Answers ).pdf
PPTX
abgs and brain death dr js chinganga.pptx
Neoplasia III.pptxjhghgjhfj fjfhgfgdfdfsrbvhv
Hypertensive disorders in pregnancy.pptx
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
Glaucoma Definition, Introduction, Etiology, Epidemiology, Clinical Presentat...
Reading between the Rings: Imaging in Brain Infections
Impression Materials in dental materials.pptx
CARDIOVASCULAR AND RENAL DRUGS.pptx for health study
04 dr. Rahajeng - dr.rahajeng-KOGI XIX 2025-ed1.pdf
ROJoson PEP Talk: What / Who is a General Surgeon in the Philippines?
Opthalmology presentation MRCP preparation.ppt
Forensic Psychology and Its Impact on the Legal System.pdf
Post Op complications in general surgery
SHOCK- lectures on types of shock ,and complications w
thio and propofol mechanism and uses.pptx
Vesico ureteric reflux.. Introduction and clinical management
ANESTHETIC CONSIDERATION IN ALCOHOLIC ASSOCIATED LIVER DISEASE.pptx
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
Infections Member of Royal College of Physicians.ppt
OSCE SERIES - Set 7 ( Questions & Answers ).pdf
abgs and brain death dr js chinganga.pptx
Ad

Diabetic Foot.pptx

  • 2. HISTORY AND PHYSICAL EXAMINATION The physician should inquire about :  any episodes of ulceration  prior amputations  known neuropathic arthropathy  impaired vision  renal history  presence of paresthesias or numbness  any symptoms of claudication  patients may deny any history of trauma or pain before the development of a foot ulcer
  • 3.  A difference in skin temperature of the foot may indicate the presence of a vascular disease
  • 4.  Diminished or absent pulses require further testing with a Doppler examination
  • 5.  The ankle-brachial index (ABI) is a useful noninvasive screening tool that is predictive of wound healing. A normal ABI is 0.9 to 1.2 while values over 1.3 suggest noncompressible vessels due to calcification.  An ABI of less than 0.5 suggests that an ulcer is unlikely to heal without vascular intervention
  • 6.  A difference in ABI of more than 0.15 between extremities is a significant finding and should be further investigated.
  • 7.  Absolute toe pressures should be higher than 70 mmHg, and a normal toe/brachial index of more than 0.7 is normal.  Toe pressures of more than 40 mmHg are associated with wound healing.
  • 8.  A neurologic examination evaluates for the presence or absence of peripheral neuropathy.
  • 9. Semmes-Weinstein monofilament  The inability to feel the 10 g of pressure from this monofilament is one of the most predictive risk factors for development of foot morbidity.  Typical screening involves 10 g monofilament testing of 10 sites on the foot
  • 11.  equivalent results can be obtained more quickly using a 4.5 g monofilament beneath both first metatarsal heads.  Decreased perception of the vibration of a 128 Hz tuning fork at the tip of the great toe also is used in clinical practice.
  • 12. ULCER CLASSIFICATION  Ince et al. found that of 410 diabetic foot ulcers, 96% of those less than 1-2 cm in dimension eventually healed without any form of amputation, while only 72% of ulcers larger than 2-3 cm did so
  • 20. LABORATORY EVALUATION  Patients with hemoglobin A1c levels higher than 7% or preoperative glucose levels of more than 200 mg/dL before ankle or hindfoot arthrodesis have a higher rate of complications, including nonunion, infection, and wound healing problems.
  • 21. If infection is suspected clinically:  complete blood count(CBC)  erythrocyte sedimentation rate (ESR)  C-reactive protein (CRP)
  • 23. TREATMENT The primary goals of treatment of diabetic foot ulcers are :  healing of the ulcer  prevention of secondary infection  recurrence  avoidance of amputation
  • 24. The most standard treatments are debridement and off-loading of the affected area
  • 25. Because of the complexities of treating diabetic feet, including : impaired blood supply osteoporotic bone neuropathy a multidisciplinary approach is most beneficial
  • 26. Expertise often is needed from subspecialists in orthopaedics, vascular Surgery , infectious disease , endocrinology, and wound nursing.
  • 27.  Vascular consultation should be considered when rest pain , claudication , or ischemic ulcers are present.
  • 28.  Endocrinology may assist if blood glucose levels cannot be controlled by the primary care practitioner or if the patient shows unusual response to standard glycemic control measures.
  • 29.  Infectious disease consultation may be helpful when a patient fails to respond to empiric antibiotic therapy.
  • 30.  Systemic factors, including glucose control , smoking, and diet, should be controlled to optimize the wound-healing environment
  • 31. Using the Wagner classification of foot ulcers:  grade 0 ulcers should be treated with serial examinations, patient education, accommodative footwear.  Grade I ulcers can be treated with debridement in the clinic and off-loading total contact cast, walking brace, or other custom footwear.
  • 32. Grade II ulcers require  surgical debridement  culture-specific antibiotics  off-loading with total anesthetic.
  • 33.  Grade III ulcers require surgical debridement or partial amputation with off-loading and culture specific antibiotics.
  • 34.  Grades IV and V ulcers require local or larger amputation based on the extent of infection.
  • 35.  In the ischemic classification of Brodsky et al :  type B ischemia should be considered for noninvasive vascular testing and reconstruction with bypass or angioplasty.
  • 36.  Type C involvement may require reconstructive vascular surgery with partial amputation
  • 37.  while type D requires thorough vascular evaluation and likely major extremity amputation.
  • 38.  Negative pressure wound therapy(NPWT) devices are another option to assist in ulcer healing.  The exact mechanism of action of NPWT is unknown;however, studies have shown that it may increase local blood flow, decrease edema, and increase the concentration of growth factors in the local wound fluid
  • 39.  Cultures of the ulcer generally are not recommended because the sensitivity in isolating the causative organism is low
  • 40.  Most ulcers are colonized with bacteria that has not invaded the deep tissue and do not require antibiotics.  When wound cultures are obtained , this should be done after thorough debridement of the wound
  • 41.  Harsh chemicals such as hydrogen peroxide and betadine should not be applied because these can damage the viable tissue in the ulcer and further delay healing.
  • 42.  Routine nail care may be provided by the physician or nurse if the patient is unable to do so.  A straight nail clipper should be used to transversely cut the nail to avoid any skin overgrowth at the medial and lateral borders, which may increase the chance of developing an ingrown nail.
  • 43.  Hyperbaric oxygen (HBO) has been used as a treatment for diabetic foot ulcers, and randomized trials have shown 54% healing using HBO compared with 25% for standard methods.
  • 44. PATIENT EDUCATION  Patient education for diabetic patients has been shown to be cost-effective, improve patient quality of life, and reduce the risk of lower extremity amputation by 50% to 85%.
  • 45.  Patients should be reminded to wear shoes at all times.  Feet should be inspected daily, and any signs of erythema, ulceration, or nail problems should be brought to the attention of the care provider.
  • 46.  Feet should be bathed daily with mild soap and a soft brush for the areas around the nails.
  • 47.  When drying the feet, attention should be paid to the web spaces because these areas often trap moisture.  If the web spaces remain overly moist, lamb’s wool may be placed in between the toes to avoid maceration.
  • 48. TOTAL CONTACT CASTING  Reducing pressure on plantar ulcers is crucial to aid healing.  Forefoot pressures can be reduced with prefabricated shoes more easily than midfoot or hindfoot ulcers.
  • 49.  Total contact casting is more effective than prefabricated shoes for the midfoot and hindfoot (Fig. 85-11).
  • 52.  A total contact cast redistributes forces from the plantar surface of the foot to the leg , which reduces the force on the foot even with weight- Bearing activity.
  • 53.  Total contact casting also is beneficial in that it reduces edema in the extremity, which is why the cast must be changed regularly to prevent loosening that can lead to further ulceration.
  • 54.  Total contact casting for plantar ulcers showed significantly better healing (89.5%) than removable prefabricated walking boots (65%) or shoes (58%).
  • 56.  This is similar to the 88% healing rate reported at 41 days with total contact casting alone in a study comparing casting alone to casting with percutaneous Achilles lengthening.
  • 57.  Patients have been shown to decrease their activity over the course of a day in a total contact cast, which reduces the stress on the foot.
  • 58.  Total contact casting is not a benign treatment, however; it has been shown to have a 6% to 17% occurrence of new ulcer formation and a 0.25% rate of permanent sequelae
  • 59. Contraindications of Total contact cast  absolute:  active or acute deep infection,gangrene(wagner grade 3-5)  deep tissue infection  osteomyelitis  exposed tendone , joint and bone  arterial insufficiency/gangrene
  • 60.  Relative:  severe obesity  ulcer depth greater than ulcer width  fragile skin  fluctuating edema  patient unwilling to have cast on limb  patient unable to comply with follow up visit  Doppler ABI less than ./4
  • 61. SURGICAL MANAGEMENT  Indications for surgical management are grossly contaminated wounds, unbraceable deformity, gastrocnemius contracture, underlying bone prominence that impedes wound healing, and failure of conservative management.
  • 62. Prophylactic surgery may be considered in patients who are at risk for wound breakdown because of joint instability or bony prominence.
  • 63.  Flexor tenotomy as treatment for isolated toe ulcerations showed over 90% healing rates in a mean of 40 days, with a 12% recurrence rate at 2-year follow up.
  • 64.  Ulcerations at the medial interphalangeal joint of the hallux can be treated by resection of the medial condyles of the proximal and distal phalanges.
  • 65.  Plantar metatarsophalangeal joint ulcerations are common, difficult to heal, and associated with a high risk of amputation.
  • 66.  Achilles tendon lengthening and/or gastrocnemius recession should be considered for patients with forefoot ulcers in whom conservative management has failed and contractures have developed.
  • 68.  Exostectomy may be required in patients with bony deformity and ulceration.  A sufficient period of off-loading with total contact casting should be completed before surgery.
  • 69.  For patients in whom other surgical management fails , who have non reconstructable vascular disease, or in whom infection is uncontrollable, amputation is the last surgical option.
  • 70.  The National Diabetes Advisory Board estimates that approximately 5% to 15% of diabetic patients will require a lower-extremity amputation in their lifetime.
  • 71.  The level of amputation depends on the location of infection and likelihood of healing of the surgical wound.
  • 72.  One-year mortality after transtibial amputation is 20%, with a 5-year mortality of 65%.  Preservation of a portion of the foot gives the patient an end-bearing limb that facilitates ambulation without a prosthesis and improves Functional outcome.
  • 73.  In the forefoot, ray resection or transmetatarsal amputation may be sufficient in a patient with palpable pulses; however, the same wound in a patient with vascular pathology may require transtibial amputation
  • 74.  In the midfoot,a talonavicular-calcaneocuboid disarticulation (Chopart) or syme amputation may allow ambulation without prosthesis.  A viable heel pad is required for a Syme amputation
  • 82.  The single most important factor predicting success of a partial foot amputation is the hemoglobin A1C level at time of surgery, with some authors recommending no elective or trauma surgery for a diabetic patient with an A1C level of more than 8% unless necessary to save life or limb.
  • 83. CHARCOT ARTHROPATHY  Diabetes is the most common cause of Charcot arthropathy today, but other etiologies include syphilis, heavy metal poisoning, alcoholic or congenital neuropathy, leprosy, rheumatoid arthritis, and idiopathic causes
  • 84.  The neurovascular, or French, theory was first proposed by Charcot and suggests that neurologic damage precedes and is responsible for the destructive changes. It proposes that damage to the nervous system causes autonomic dysfunction, which increases local blood flow due to arteriovenous shunting and leads to bone resorption
  • 85.  The neurotraumatic, or German, theory supported by Virchow and Volkman suggests that repetitive microtrauma causes the bony changes due to absent protective mechanisms.
  • 86. CLASSIFICATION  Type 1 involving the tarsometatarsal and naviculocuneiform joints is most common (60%). Midfoot involvement, specifically the tarsometatarsal joints characterized by hindfoot valgus as a result of forefoot abduction with a contracted gastrocsoleus complex
  • 87.  Type 2 is the second most common type (25%) and primarily involves the hindfoot, including the subtalar, talonavicular, and calcaneocuboid joints, and may also progress to a rocker-bottom deformity
  • 89.  Type 3A (10%) involves the ankle and often results in ulcerations over the prominent malleoli. Ankle involvement generally requires operative intervention because of marked instability.  Type 3B (5%) presents as a pathologic fracture of the calcaneal tuberosity from avulsion
  • 92. TREATMENT  Stage 1 disease is treated with a total contact cast, which offloads the involved region and provides stability and alignment through the healing phases.
  • 93.  stage 2 , patients can be transitioned into a prefabricated boot or a custom- molded ankle-foot-orthosis.
  • 94.  When consolidation is complete and swelling resolves completely (stage 3) intensive treatment, up to 50% may require surgical intervention
  • 95.  Vitamin D supplementation should be considered for all patients because research has shown frequent hypovitaminosis D in diabetic patients and clarified its role in the pathogenesis and treatment of Charcot arthropathy.
  • 96.  The primary goals of surgical intervention are to prevent ulceration, infection, and amputation by decreasing sites of underlying pressure and improving alignment and stability of the foot.
  • 97.  Exostectomy is most beneficial in Brodsky type 1 deformities in which tarsometatarsal destruction leads to rockerbottom deformity and increased midfoot plantar pressures
  • 98.  Patients with instability and resultant pain or ulceration may be best treated with arthrodesis
  • 99.  Type 1 deformities generally require midfoot arthrodesis, while type 2 deformities require triple arthrodesis
  • 100.  In patients with uncontrollable infection or failed operative treatment, amputation preserving as much length as possible may be the best option
  • 101.  An estimated 2% to 3% of patients with Charcot arthropathy have amputations